Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128635) titled 'Application of Reduced-Dose VMAT-TBI Combined with Dual Alkylating Agents Conditioning Regimen in Umbilical Cord Blood Stem Cell Transplantation' on July 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Army Medical Center of PLA
Condition:
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-28
Target Sample Size: Umbilical cord blood transplant group:28;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=333866
Disclaimer: Curated by HT Syndicat...